Pay in 4 interest-free payments of $6.05 Learn more
Ships within 48 hours · Estimated delivery Sep 5 - Sep 10
An analysis of six clinical trials found that AOD 9604 had a safety profile comparable to placebo and did not act through the IGF-1 pathway
Why Fasted Administration Matters AOD-9604 stimulates lipolysis through beta-3 adrenergic receptor activation, promoting the release of stored fatty acids for energy utilization
Consult a licensed clinician before making any health-related decision.
Let the peptide disperse naturally
US$ 28.64
US$ 25.46
US$ 21.66
US$ 29.41
US$ 26.91
US$ 22.52
US$ 28.42
US$ 29.06
